Sustained remission and long-term survival of secondary central nervous system involvement by aggressive B-cell lymphoma after combination treatment of systemic high-dose chemotherapy and intrathecal rituximab

被引:16
|
作者
Liu, Chun-Yu [1 ,2 ]
Teng, Hao-Wei [1 ,2 ]
Lirng, Jiing-Feng [2 ]
Chiou, Tzeon-Jye [2 ,3 ]
Chen, Po-Min [1 ,2 ]
Hsiao, Liang-Tsai [1 ,2 ]
机构
[1] Taipei Vet Gen Hosp, Div Hematol & Oncol, Dept Med, Taipei 112, Taiwan
[2] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan
[3] Taipei Vet Gen Hosp, Div Transfus Med, Dept Med, Taipei 112, Taiwan
关键词
D O I
10.1080/10428190802311375
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:2018 / 2021
页数:4
相关论文
共 50 条
  • [21] High-dose chemotherapy with hematopoietic stem cell transplantation for the treatment of primary central nervous system lymphoma
    Campen, Christopher J.
    Tombleson, Rebecca L.
    Green, Myke R.
    JOURNAL OF NEURO-ONCOLOGY, 2011, 101 (03) : 345 - 355
  • [22] Rituximab with High Dose Methotrexate in the Management of Primary Central Nervous System Diffuse Large B-Cell Lymphoma
    Kansara, Roopesh R.
    Shenkier, Tamara
    Connors, Joseph M.
    Gerrie, Alina S.
    Klasa, Richard
    Savage, Kerry J.
    Sehn, Laurie H.
    Villa, Diego
    BLOOD, 2014, 124 (21)
  • [23] Rituximab maintenance therapy achieves a long term remission in a patient with aggressive lymphoma who relapsed after high dose chemotherapy.
    Weide, R
    Heymanns, J
    Koeppler, H
    BLOOD, 2003, 102 (11) : 303B - 303B
  • [24] Long-Term Survival with Favorable Cognitive Outcome after Chemotherapy in Primary Central Nervous System Lymphoma
    Juergens, Annika
    Pels, Hendrik
    Rogowski, Sabine
    Fliessbach, Klaus
    Glasmacher, Axel
    Engert, Andreas
    Reiser, Marcel
    Diehl, Volker
    Vogt-Schaden, Marlies
    Egerer, Gerlinde
    Schackert, Gabriele
    Reichmann, Heinz
    Kroschinsky, Frank
    Bode, Udo
    Herrlinger, Ulrich
    Linnebank, Michael
    Deckert, Martina
    Fimmers, Rolf
    Schmidt-Wolf, Ingo G. H.
    Schlegel, Uwe
    ANNALS OF NEUROLOGY, 2010, 67 (02) : 182 - 189
  • [25] Phase II, Single-Center, Prospective Study of Intrathecal Thiotepa for the Prophylaxis of Secondary Central Nervous System Involvement in Highly Aggressive B-Cell Lymphoma
    Li, Cong
    Lei, Tao
    Yu, Haifeng
    Chen, Xi
    Peng, Shuailing
    Han, Shuiyun
    Yang, Haiyan
    BLOOD, 2023, 142
  • [26] Central nervous system relapse of systemic non-Hodgkin's lymphoma: Results of treatment based on high-dose methotrexate combination chemotherapy
    Bokstein, F
    Lossos, A
    Lossos, IS
    Siegal, T
    LEUKEMIA & LYMPHOMA, 2002, 43 (03) : 587 - 593
  • [27] Secondary central nervous system involvement in 599 patients with diffuse large B-cell lymphoma: are there any changes in the rituximab era?
    Lijuan Deng
    Yuqin Song
    Jun Zhu
    Wen Zheng
    Xiaopei Wang
    Yan Xie
    Ningjing Lin
    Meifeng Tu
    Lingyan Ping
    Zhitao Ying
    Weiping Liu
    Chen Zhang
    International Journal of Hematology, 2013, 98 : 664 - 671
  • [28] Secondary central nervous system involvement in 599 patients with diffuse large B-cell lymphoma: are there any changes in the rituximab era?
    Deng, Lijuan
    Song, Yuqin
    Zhu, Jun
    Zheng, Wen
    Wang, Xiaopei
    Xie, Yan
    Lin, Ningjing
    Tu, Meifeng
    Ping, Lingyan
    Ying, Zhitao
    Liu, Weiping
    Zhang, Chen
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 98 (06) : 664 - 671
  • [29] Long-term survival after high-dose salvage chemotherapy in patients with germ cell tumors
    Rick, O
    Beyer, J
    Schwella, N
    Kingreen, D
    Kirsch, A
    Schleicher, J
    Krusch, A
    Huhn, D
    Siegert, W
    BONE MARROW TRANSPLANTATION, 1998, 21 : S228 - S228
  • [30] Long-term Survival in Patients with Mantle Cell Lymphoma after Total Body Irradiation, High-dose Chemotherapy and Stem Cell Transplantation
    Kroger, K.
    Siats, J.
    Stelljes, M.
    Lenz, G.
    Eich, H. T.
    Reinartz, G.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S172 - S172